Connect with us

Hi, what are you looking for?

Jewish Business News

Money

Are Cracks Showing Between The New Controlling Shareholders At IDB ?


An argument broke out between the two at a meeting at Menorah Mivtachim.

Eduardo Elsztain  - MOTI BEN MOSHE - IDB

Moti Ben-Moshe                                                      Eduardo Elsztain

Will the business partnership between the new controlling shareholders at IDB Holding Corp. Ltd. (TASE:IDBH), Eduardo Elsztain and Moti Ben-Moshe, stand the test of time? Quite a bit has been written about the differences in the two men’s personalities, as well as their different approaches to business.

Another disagreement broke out a few days earlier over the appointment of IDB Development chairman Aharon Fogel as chairman of its subsidiary,  Discount Investment Corporation (TASE:DISI). Ben-Moshe urged the appointment, but Elzstain opposed it. They ultimately decided to appoint Fogel as a director on Discount Investment’s board, at least for now.

Sources close to Elsztain and Ben-Moshe told “Globes” that the tense atmosphere is exacerbated by Dankner’s investigation into Ben-Moshe’s businesses. Last week, Dankner filed a motion with the court that included additional findings about Ben-Moshe, including a probe by the German energy regulator into ExtraEnergie GmbH, owned by Ben-Moshe.

Ben-Moshe and Elsztain said in response, “We are happy with the partnership, and succeeding in working together to meet all the challenges. We do not respond to rumors.”

Published by Globes [online], Israel business news – www.globes-online.com

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Newsletter

Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

empty

The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

Business

Now Platika joins and elite club of $10 billion plus Israeli firms.

Advertisement
cialis